Admonita, UAB

Company age: 8 y. 0 mo.

Update

Company overview

Company name Admonita, UAB
Company code 304916723
VAT code LT100012048518
Registered address Vilnius, Raudonės g. 59, LT-12205
Registration date 2018-09-17 Company age: 8 y.
Phone Phone
Email Email
Website None
Company manager For registered members only Log in
Revenue (2025) 48,459 € -35% History
Profit (2025) 5,985 € -47% History
Share capital 2,500 €
Number of employees 1 History
Managed vehicles 1 List
Current SODRA debt No debt Read more
Days of debt to SODRA per year 1 days
Current VMI debt 1,120 € From: 2026-07-30 Read more
Financial statements All submitted
Legal form Private Limited Liability Company
NACE activity Retail sale of pharmaceutical products
Ownership form Private without foreign capital
Viešųjų pardavimų suma pask. 12 mėn 3,450 € List

Download a detailed company report

Make confident decisions with all the information about Admonita, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Admonita, UAB (company code 304916723) is a private limited liability company registered on 2018-09-17 and currently operational. It is a micro-sized private enterprise with Lithuanian ownership and CEO-only governance, operating in the national private non-financial companies sector. The company is based in Vilnius, at Raudones g. 59, LT-12205, Vilniaus m. sav., Vilniaus apskr. Its registered activity is EVRK G.47.73.00, Retail sale of pharmaceutical products. The share capital is EUR 2.5K.

Financially, the company reported revenue of EUR 48.5K in 2025, down from EUR 74.8K in 2024 and EUR 86.1K in 2023. Despite the decline in sales, it remained profitable in 2025 with net profit of EUR 6.0K and a profit margin of 12.4%. Equity increased to EUR 43.8K, while total assets stood at EUR 76.7K and liabilities at EUR 33.2K. The latest available staff data shows an average of 1 employee in 2025 and so far in 2026, compared with 2 in 2024.